• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在约旦一家三级癌症中心对50只因视网膜母细胞瘤而主要被摘除的眼睛进行的组织病理学分析。

A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.

作者信息

Yousef Yacoub A, Hajja Yasmin, Nawaiseh Ibrahim, Mehyar Mustafa, Sultan Iyad, Deebajah Rasha, Rawashdeh Khalil, Khurma Samer, Jaradat Imad, Al-Hussaini Maysa

机构信息

Department of Surgery, King Hussein Cancer Center, AMMAN, JORDAN.

出版信息

Turk Patoloji Derg. 2014;30(3):171-7. doi: 10.5146/tjpath.2014.01260.

DOI:10.5146/tjpath.2014.01260
PMID:24913302
Abstract

OBJECTIVE

To analyze the histopathologic features of the eyes with intraocular retinoblastoma primarily treated by enucleation in a tertiary cancer center in Jordan.

MATERIAL AND METHOD

A retrospective case series of 50 eyes for 49 patients who had pathologically confirmed retinoblastoma after enucleation as primary therapy. The main outcome measures included demographics, laterality, international classification of intraocular retinoblastoma, choroid invasion, optic nerve invasion, anterior chamber invasion, and tumor differentiation.

RESULTS

The median age at enucleation was 30 months. Twenty-seven (55%) patients were males, and 19 (39%) patients had bilateral retinoblastoma. High risk pathological features were seen as massive choroid invasion in 9 (18%) eyes, post-laminar optic nerve invasion in 7 (14%) eyes, and anterior chamber, iris or ciliary body invasion in 7 (14%) eyes. Thirty-seven (74%) tumors were well/moderately differentiated, and 13 (26%) were poorly differentiated. Poorly differentiated tumors presented later (median 31 months) than well/ moderately differentiated tumors (26 months) and were associated with a higher incidence of high-risk pathological features. No single ICRB group C eye had high-risk pathological features, while 17% and 4% of group D eyes and 28% and 33% of group E eyes had massive choroid invasion and post-laminar optic nerve invasion, respectively. Eighteen (36%) patients received adjuvant chemotherapy for high risk pathological features, and at median follow up of 40 months, no single case had metastasis or was dead.

CONCLUSION

Our pathologic findings were similar to the developed world. They were supportive of the predictive power of the international classification of retinoblastoma staging system for the likelihood of high risk pathological features. Poorly differentiated tumors were associated with a higher incidence of high risk pathological features than well/moderately differentiated tumors.

摘要

目的

分析在约旦一家三级癌症中心主要通过眼球摘除术治疗的眼内视网膜母细胞瘤的组织病理学特征。

材料与方法

对49例患者的50只眼进行回顾性病例系列研究,这些患者在眼球摘除术后经病理证实患有视网膜母细胞瘤,且眼球摘除术为主要治疗方法。主要观察指标包括人口统计学特征、患侧、眼内视网膜母细胞瘤的国际分类、脉络膜侵犯、视神经侵犯、前房侵犯以及肿瘤分化情况。

结果

眼球摘除术时的中位年龄为30个月。27例(55%)患者为男性,19例(39%)患者患有双侧视网膜母细胞瘤。高风险病理特征表现为9只眼(18%)出现大量脉络膜侵犯,7只眼(14%)出现筛板后视神经侵犯,7只眼(14%)出现前房、虹膜或睫状体侵犯。37只眼(74%)的肿瘤为高分化/中分化,13只眼(26%)为低分化。低分化肿瘤出现时间较晚(中位时间31个月),高于高分化/中分化肿瘤(26个月),且与高风险病理特征的发生率较高相关。国际视网膜母细胞瘤分类(ICRB)中没有C组的眼具有高风险病理特征,而D组眼和E组眼中分别有17%和4%出现大量脉络膜侵犯,28%和33%出现筛板后视神经侵犯。18例(36%)患者因高风险病理特征接受了辅助化疗,中位随访40个月时,没有一例发生转移或死亡。

结论

我们的病理结果与发达国家相似。这些结果支持视网膜母细胞瘤分期系统的国际分类对于高风险病理特征可能性的预测能力。低分化肿瘤比高分化/中分化肿瘤具有更高的高风险病理特征发生率。

相似文献

1
A histopathologic analysis of 50 eyes primarily enucleated for retinoblastoma in a tertiary cancer center in Jordan.在约旦一家三级癌症中心对50只因视网膜母细胞瘤而主要被摘除的眼睛进行的组织病理学分析。
Turk Patoloji Derg. 2014;30(3):171-7. doi: 10.5146/tjpath.2014.01260.
2
High-risk retinoblastoma based on international classification of retinoblastoma: analysis of 519 enucleated eyes.基于国际视网膜母细胞瘤分类的高危视网膜母细胞瘤:519 例眼球摘除眼分析。
Ophthalmology. 2013 May;120(5):997-1003. doi: 10.1016/j.ophtha.2012.10.044. Epub 2013 Feb 8.
3
High-Risk Histopathology Features in Primary and Secondary Enucleated International Intraocular Retinoblastoma Classification Group D Eyes.原发性和继发性眼内摘除的国际眼内视网膜母细胞瘤分类组 D 眼中的高危组织病理学特征。
Ophthalmology. 2017 Jun;124(6):851-858. doi: 10.1016/j.ophtha.2017.01.048. Epub 2017 Mar 13.
4
A histopathologic analysis of eyes primarily enucleated for advanced intraocular retinoblastoma from a developing country.发展中国家因眼内晚期视网膜母细胞瘤行眼球摘除术的眼部组织病理分析。
Arch Pathol Lab Med. 2012 Feb;136(2):190-3. doi: 10.5858/arpa.2010-0759-OA.
5
PREDICTIVE VALUE OF TNM CLASSIFICATION, INTERNATIONAL CLASSIFICATION, AND REESE-ELLSWORTH STAGING OF RETINOBLASTOMA FOR THE LIKELIHOOD OF HIGH-RISK PATHOLOGIC FEATURES.视网膜母细胞瘤的TNM分类、国际分类及里斯-埃尔斯沃思分期对高危病理特征可能性的预测价值
Retina. 2015 Sep;35(9):1883-9. doi: 10.1097/IAE.0000000000000547.
6
Clinical predictors of high risk histopathology in retinoblastoma.视网膜母细胞瘤高危组织病理学的临床预测因素。
Pediatr Blood Cancer. 2012 Mar;58(3):356-61. doi: 10.1002/pbc.23239. Epub 2011 Jun 30.
7
Comparison of high-risk histopathological features in eyes with primary or secondary enucleation for retinoblastoma.视网膜母细胞瘤原发性或继发性眼球摘除眼中高危组织病理学特征的比较。
Br J Ophthalmol. 2015 Oct;99(10):1366-71. doi: 10.1136/bjophthalmol-2014-306364. Epub 2015 Apr 14.
8
The impact of growth patterns of retinoblastoma (endophytic, exophytic, and mixed patterns).视网膜母细胞瘤生长模式(内生型、外生型和混合型)的影响。
Turk Patoloji Derg. 2015;31(1):45-50. doi: 10.5146/tjpath.2014.01278.
9
Pre-enucleation chemotherapy for eyes severely affected by retinoblastoma masks risk of tumor extension and increases death from metastasis.眼内期化疗治疗严重受视网膜母细胞瘤影响的眼睛会掩盖肿瘤扩散的风险,并增加因转移而死亡的风险。
J Clin Oncol. 2011 Mar 1;29(7):845-51. doi: 10.1200/JCO.2010.32.5332. Epub 2011 Jan 31.
10
Correlation between clinical features, magnetic resonance imaging, and histopathologic findings in retinoblastoma: a prospective study.视网膜母细胞瘤的临床特征、磁共振成像与组织病理学表现的相关性:一项前瞻性研究。
Ophthalmology. 2012 Apr;119(4):850-6. doi: 10.1016/j.ophtha.2011.09.037. Epub 2012 Jan 3.

引用本文的文献

1
Outcomes and Predictive Factors of I-125 Plaque Therapy for Refractory Retinoblastoma.I-125 敷贴治疗难治性视网膜母细胞瘤的疗效及预测因素
J Clin Med. 2025 Mar 6;14(5):1778. doi: 10.3390/jcm14051778.
2
Optimizing Surgical Management for Rhegmatogenous Retinal Detachment in Eyes with Active Retinoblastoma: A Safety-Driven Approach.优化活动性视网膜母细胞瘤患儿视网膜脱离的手术治疗:一种以安全为导向的方法。
J Clin Med. 2024 Apr 25;13(9):2511. doi: 10.3390/jcm13092511.
3
Clinical and Histopathologic Predictors of Survival Among Children With Retinoblastoma From Two Tertiary Health Facilities in Uganda.
乌干达两家三级医疗机构中视网膜母细胞瘤患儿生存情况的临床和组织病理学预测因素
Cureus. 2023 Dec 15;15(12):e50605. doi: 10.7759/cureus.50605. eCollection 2023 Dec.
4
Clinicodemographic profile, management, and treatment outcomes in advanced retinoblastoma at a tertiary care center in North India.印度北部一家三级医疗中心晚期视网膜母细胞瘤的临床人口统计学特征、管理及治疗结果
Indian J Ophthalmol. 2024 May 1;72(5):653-658. doi: 10.4103/IJO.IJO_1849_23. Epub 2023 Dec 15.
5
Causes of death and survival analysis for patients with retinoblastoma in Jordan.约旦视网膜母细胞瘤患者的死因及生存分析
Front Med (Lausanne). 2023 Sep 4;10:1244308. doi: 10.3389/fmed.2023.1244308. eCollection 2023.
6
Adjuvant Chemotherapy Improves Survival for Children With Massive Choroidal Invasion of Retinoblastoma.辅助化疗可提高视网膜母细胞瘤眼内巨大脉络膜侵犯患儿的生存率。
Invest Ophthalmol Vis Sci. 2023 Aug 1;64(11):27. doi: 10.1167/iovs.64.11.27.
7
Chemotherapy induced histopathological changes in retinoblastoma, assessment of high risk predictive factors & its correlation with comorbid conditions.化疗引起的视网膜母细胞瘤组织病理学变化、高危预测因素评估及其与合并症的相关性。
Pak J Med Sci. 2022 Jan;38(2):362-368. doi: 10.12669/pjms.38.ICON-2022.5786.
8
High risk histopathological factors in retinoblastoma in upfront enucleated eyes: An experience from a tertiary care centre of Pakistan.初诊时行眼球摘除的视网膜母细胞瘤的高风险组织病理学因素:来自巴基斯坦一家三级医疗中心的经验。
Pak J Med Sci. 2022 Jan;38(2):369-374. doi: 10.12669/pjms.38.ICON-2022.5787.
9
Management and Outcomes of Unilateral Group D Tumors in Retinoblastoma.视网膜母细胞瘤单侧D组肿瘤的管理与预后
Clin Ophthalmol. 2021 Jan 7;15:65-72. doi: 10.2147/OPTH.S282741. eCollection 2021.
10
Update on pathology of retinoblastoma.视网膜母细胞瘤病理学进展
Int J Ophthalmol. 2018 Dec 18;11(12):2011-2016. doi: 10.18240/ijo.2018.12.22. eCollection 2018.